ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma · Brain Tumor · Cannabis · Brain Tumor, Recurrent

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Glan Clwyd Hospital, Bodelwyddan, Denbighshire, United Kingdom

  • Mount Vernon Hospital, The Hillingdon Hospitals NHS Foundation Trust, Northwood, Middlesex, United Kingdom

    Contact: Principal Investigator (Thomas Carter)
  • Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom

    Contact: Principal Investigator (Rafael Moleron)
  • Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom

  • Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

    Contact: Principal Investigator (Sara Meade)
  • Bristol Haematology & Oncology Centre, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, United Kingdom

  • Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

    Contact: Principal Investigator (Fiona Harris)
  • Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom

    Contact: Principal Investigator (Jillian MacLean)
  • Western General Hospital, NHS Lothian, Edinburgh, United Kingdom

  • Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde, Glasgow, United Kingdom

  • Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom

    Contact: Study coordinator (Sanjay Dixit)
  • St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Contact: Principal Investigator (Fiona Collinson)
  • St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom

    Contact: Principal Investigator (Rachel Lewis)
  • Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

    Contact: Principal Investigator (Lucy Brazil)
  • Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom

    Contact: Principal Investigator (Matthew Williams)
  • Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom

    Contact: Principal Investigator (Samantha Forner)
  • The Christie Hospital, The Christie NHS Foundation Trust, Manchester, United Kingdom

    Contact: Principal Investigator (Catherine McBain)
  • Clatterbridge Cancer Centre, The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral, United Kingdom

    Contact: Principal Investigator (Shaveta Mehta)
  • City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

    Contact: Principal Investigator (Karen Foweraker)
  • Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

    Contact: Study coordinator (Juliet Brock)
  • Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom

    Contact: Study coordinator (Elizabeth Lim)
  • Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Study leads
  • Fiona Collinson, MBBS, BSc, MRCP, FRCR, PhD

    Principal Investigator

    University of Leeds